Disease Info Card

Gilles De La Tourette Syndrome

Information about Gilles De La Tourette Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Gilles De La Tourette Syndrome

Most recent studies have shown that Gilles De La Tourette Syndrome shares some biological mechanisms with anxiety-disorders, attention-deficit-hyperactivity-disorder, autistic-disorder, behavioral-tic, chorea, depressive-disorder, dyskinetic-syndrome, dystonia-disorders, huntington-disease, malnutrition, mental-disorders, motor-tics, movement-disorders, nervous-system-disorder, obsessive-compulsive-behavior, obsessive-compulsive-disorder, osteochondritis-dissecans, parkinson-disease, schizophrenia, tic-vocal.

Among the many pathways, these few ones have gauged particular interests from scientists studying Gilles De La Tourette Syndrome, and have been seen in publications frequently: Aging, Brain Development, Cell Adhesion, Cognition, Dopamine Uptake, Excretion, Habituation, Hypersensitivity, Immune Response, Innervation, Localization, Myelination, Pathogenesis, Prepulse Inhibition, Reflex, Secretion, Startle Response, Translation, Transport

Quite a number of genes have been found to play important roles in Gilles De La Tourette Syndrome, such as ARNTL, CACNA1C, COMT, CSF2, DBH, DES, DIO2, DRD2, DRD4, LAMC2, LRP2, MCF2L, PRL, SLC6A3, SLC6A4, SLITRK1, SSB, TBXAS1, TYMS. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.